Gilteritinib Yields Five-Year Remission in Relapsed Acute Myeloid Leukemia Case
A patient with relapsed FLT3-mutated acute myeloid leukemia achieved a durable complete remission exceeding five years after switching to gilteritinib.
Tag: FLT3-D835V
POPULAR NEWS
-
Modeling Reveals How Silica Gold Nanoparticles Reshape Optical Energy and Fields
-
Intravenous Iron Formulations Spur Divergent Muscle Recovery in Iron Deficiency Anaemia
-
Pararectal Leiomyosarcoma Diagnosed After Laparoscopic Hysterectomy Without Morcellation
-
Bone and Soft Tissue Combined: New Imaging Method Builds 3D Shape Models of the Foot and Ankle